-+ 0.00%
-+ 0.00%
-+ 0.00%

Senti Bio CEO Timothy Lu to present logic-gated NK cell therapy at AACR meeting

PUBT·04/13/2026 13:03:59
Listen to the news
Senti Bio CEO Timothy Lu to present logic-gated NK cell therapy at AACR meeting
  • Senti Biosciences CEO Timothy Lu will present at AACR Annual Meeting 2026 in San Diego on April 17, 2026.
  • Talk will cover logic-gated engineered NK cell therapy SENTI-202, including clinical trial results in relapsed or refractory acute myeloid leukemia.
  • Educational session scheduled for 3:00-4:30 p.m. PT.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Senti Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604130900PRIMZONEFULLFEED9688224) on April 13, 2026, and is solely responsible for the information contained therein.